Catalyst Wire Dossier Catalyst Wire Dossier

Febuxostat Tablets 40 mg

Febuxostat · Macleods Pharmaceuticals Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Febuxostat Tablets 40 mg, covering 2023-09-28 to 2023-09-28. Get the full timeline:

Most recent: FDA Approved: FEBUXOSTAT — Original Application (Macleods Pharmaceuticals Limited)

See pricing